1 |
Kim HW, Kim HS, Yang DO, Kim SJ. Immune responses of plasma derived HB vaccine for three years follow up. Korean J Med 1990;39:195-203
|
2 |
Chang JY, Jeong SJ, Kim SK, Son BK, Hong YJ, Hong KS. Positive rate of HBsAg in school children in Incheon area. Korean J Pediatr Infect Dis 2003;10:153-8
|
3 |
Kim CY. Immunoprophylaxis of hepatitis B. J Korean Med Assoc 1984;27:804-14
|
4 |
Williams IT, Goldstein ST, Tufa J, TauilliiI S, Margolis HS, Mahoney FJ. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 2003;22:157-63
|
5 |
Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants : 10-year follow-up. J Infect Dis 1999;179:1319-25
DOI
ScienceOn
|
6 |
Duval B, Gilca V, Boulianne N, De Wals P, Masse R, Trudeau G, et al. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J 2005;24:213-8
DOI
ScienceOn
|
7 |
Lai CL, Lau JY, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc seropositivity by ELISA : implications and the role of radioimmunoassay. J Med Virol 1992;36:180-3
DOI
ScienceOn
|
8 |
McIntyre A, Nimmo GR, Wood GM, Tinniswood RD, Kerlin P. Isolated hepatitis B core antibody - can response to hepatitis B vaccine help elucidate the cause- Aust N Z J Med 1992;22:19-22
DOI
ScienceOn
|
9 |
Lai CL, Wong BC, Yeoh EK, Lim WL, Chang WK, Lin HJ. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasmaderived vaccine in children : immunogenicity and anamnestic responses. Hepatology 1993;18:763-7
DOI
ScienceOn
|
10 |
Epidemiology and prevention of vaccine-preventable diseases, 8th ed. Published by National Immunization Program, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. chapter 15. Hepatitis B. 2005:207
|
11 |
West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J 1994;13:745-7
DOI
ScienceOn
|
12 |
Aoki SK, Finegold D, Kuramoto IK, Douville C, Richards C, Randell R, et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion 1993;33: 362-7
DOI
ScienceOn
|
13 |
Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-result of a 10-year study. J Infect Dis 1997;175:674-7
DOI
ScienceOn
|
14 |
European consensus group on hepatitis B immunity. Are booster immunization needed for lifelong hepatitis B immunity? Lancet 2000;355:561-5
DOI
ScienceOn
|
15 |
Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 2004;23:650-5
DOI
ScienceOn
|
16 |
Lee SJ, Han HK, Um MR, Choi KH, Lee MN, Yoo BH. Immune response to hepatitis B revaccination. Korean J Infect Dis 1996;28:59-66
DOI
|
17 |
Guideline of Immunization, 5th ed. The Korean Pediatric Society 2002:57
|
18 |
Szmuness W, Stevens CE, Oleszko WR, Goodman A. Passive- active immunisation against hepatitis B : immunogenicity studies in adult Americans. Lancet 1981;1:575-7
|
19 |
West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen : implications for policy on booster vaccination. Vaccine 1996;14:1019-27
DOI
ScienceOn
|
20 |
Ding L, Zhang M, Wang Y, Zhou S, Kong W, Smego RA Jr. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect Dis 1993;17:475-9
DOI
ScienceOn
|
21 |
Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Harpster AP. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med 1991;151:1634-6
DOI
|
22 |
Poland GA, Jacobson RM. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004;351:2832-8
DOI
ScienceOn
|
23 |
Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, et al. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United State. N Engl J Med 1980;303:833-41
DOI
ScienceOn
|
24 |
Williams JL, Christensen CJ, McMahon BJ, Bulkow LR, Cagle HH, Mayers JS, et al. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine 2001;19:4081-5
DOI
ScienceOn
|
25 |
Hepatitis B virus : a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee(ACIP). MMWR Recomm Rep 1991;40:1-25
|
26 |
Seto D, West DJ, Ioli VA. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J 2002;21:793-5
DOI
ScienceOn
|
27 |
Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Longterm immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003;187:134-8
DOI
ScienceOn
|
28 |
Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units : II, Haemodialysis patients. Lancet 1981;1:797-800
|
29 |
Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in medical staff of hemodialysis units. N Engl J Med 1982;307:1481-6
DOI
ScienceOn
|
30 |
Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-8
|
31 |
Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B : the role of vaccine immunogenicity in immune memory. Vaccine 2000;19:877-85
DOI
ScienceOn
|
32 |
Waston BM, Di Prinzio S, West D. Persistence of hepatitis B antibody and anamnestic response to a booster dose in healthy adolescents and adults. Abstract 32, the 32nd National Immunization Conference : 1998 July 21-24; Atlanta, GA
|